The U.S. pharmaceutical giant Moderna has finalised arrangements with the Australian and Victorian governments to build the world’s first mRNA production facility located on a university campus.
The construction at Melbourne’s Monash University is expected to commence at the end of 2022, with production anticipated to begin by the end of 2024.
